New board appointment at Orexigen
05 March 2010
Zoe Dann
Please Login to read the full article.
05 March 2010
Zoe Dann
zoe.dann@informa.com
Orexigen Therapeutics, a US biopharmaceutical company focused on the treatment of obesity, has elected
Dr Peter Honig to its board of directors. Dr Honig has more than 20 years' clinical and regulatory policy experience from past roles with Merck & Co and the US FDA. Most recently, he was senior...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Asia Beat: Takeda + Nycomed = panic buy or strategic masterstroke?
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
- Patient input, safety focus urged for final PDUFA V touchups
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
